Correlation between antibiotic consumption and carbapenem-resistant Acinetobacter baumannii causing health care-associated infections at a hospital from 2005 to 2010

doi:10.1016/j.jmii.2014.02.004

Chia Nan University of Pharmacy & Science Institutional Repository > 藥理學院 > 保健營養系(所) > 期刊論文 > Item 310902800/29679

請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/29679

標題:	Correlation between antibiotic consumption and carbapenem-resistant Acinetobacter baumannii causing health care-associated infections at a hospital from 2005 to 2010
作者:	Tan, Che-Kim Tang, Hung-Jen Lai, Chih-Cheng Chen, Yun-Ying Chang, Ping-Chin Liu, Wei-Lun
貢獻者:	保健營養系
關鍵字:	Acinetobacter baumannii Antibiotic resistance Antibiotic use Health care-associated infection
日期:	2015-10
上傳時間:	2016-04-19 19:04:21 (UTC+8)
出版者:	Elsevier Taiwan
摘要:	Background/Purpose: This study investigated the correlation between antibiotic consumption and the incidence of health care-associated infections (HCAIs) caused by imipenem-resistant Acinetobacter baumannii (IRAB) at a hospital in Taiwan from 2005 to 2010. Methods: Data on annual consumption (defined daily dose per 1000 patient-days) of extended-spectrum cephalosporins, beta-lactam-beta-lactamase inhibitor combinations, carbapenems, aminoglycosides, and fluoroquinolones from 2005 to 2010 were analyzed. Yearly aggregated data on the number of nonduplicate clinical IRAB isolates causing HCAI were collected. The incidence rates of HCAI caused by IRAB were defined as the number of patients infected with IRAB per 1000 inpatient-days. Results: The trend of total consumption (defined daily dose per 1000 patient-days) of extended-spectrum cephalosporins, carbapenems, and fluoroquinolones was significantly increased, but the use of aminoglycosides decreased during 2005 to 2010. During the same period, the incidence of HCAI caused by IRAB gradually increased. The consumptions of carbapenems and fluoroquinolones were positively correlated with the incidence of HCAI caused by IRAB. There was no significant association between the use of extended-spectrum cephalosporins, beta-lactam-beta-lactamase inhibitor combinations, and aminoglycosides and the incidence of HCAI caused by IRAB. Conclusion: The increasing use of carbapenems and fluoroquinolones was associated with the increasing incidence of HCAI caused by IRAB.
關聯:	Journal of Microbiology Immunology And Infection, v.48 n.5, pp.540-544
顯示於類別:	[保健營養系(所) ] 期刊論文

文件中的檔案:

檔案	描述	大小	格式	瀏覽次數
index.html		0Kb	HTML	1711	檢視/開啟

在CNU IR中所有的資料項目都受到原著作權保護.

TAIR相關文章

資料載入中.....